Compare SNPS & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNPS | HCA |
|---|---|---|
| Founded | 1986 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Hospital/Nursing Management |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.2B | 87.7B |
| IPO Year | 1994 | 2009 |
| Metric | SNPS | HCA |
|---|---|---|
| Price | $377.10 | $425.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 20 |
| Target Price | ★ $540.71 | $511.84 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 05-27-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | 3.27 | ★ 7.15 |
| Revenue | $5,081,542,000.00 | ★ $75,600,000,000.00 |
| Revenue This Year | $39.22 | $5.11 |
| Revenue Next Year | $10.73 | $4.86 |
| P/E Ratio | $112.20 | ★ $59.28 |
| Revenue Growth | ★ 20.87 | 7.08 |
| 52 Week Low | $366.00 | $353.99 |
| 52 Week High | $539.48 | $556.52 |
| Indicator | SNPS | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 56.84 |
| Support Level | N/A | $421.48 |
| Resistance Level | $444.66 | $426.67 |
| Average True Range (ATR) | 17.53 | 13.43 |
| MACD | -4.81 | 0.54 |
| Stochastic Oscillator | 4.25 | 73.60 |
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.